Study objectives: Static mouth pressure during maximal inspiratory efforts is commonly used to evaluate inspiratory muscle strength. However, maximal inspiratory pressure (MIP) presents some potential limitations likely to be overcome by the measure of mouth pressure during a maximal sniff maneuver in patients with respiratory muscle weakness. The aim of the present study was to assess whether mouth pressure during sniff maneuver (Pmosn) is a better index of inspiratory muscle strength than MIP in patients with neurologic and neuromuscular diseases (NNMD) with and without inspiratory muscle weakness. Subjects and measurements: Both MIP and Pmosn were measured in 30 patients affected by various types of NNMD and in 41 control subjects. Pmosn was measured with a 5-cm latex balloon-catheter system, the balloon being held in the oral cavity with the lips closed. Results: In control subjects, MIP was either similar (in female subjects) or higher (in male subjects) than Pmosn, the variation coefficients for the two tests being similar both in male subjects (19.3% vs 19.1% for MIP and Pmosn, respectively) and in female subjects (27.5% vs 26.2%, respectively). There was no difference in the Pmosn/MIP ratios observed in the different diseases (one-way analysis of variance, F ‫؍‬ 0.29, p ‫؍‬ 0.91). In control subjects, a significant inverse relationship between Pmosn/MIP ratio and MIP (r ‫؍‬ ؊ 0.66, p < 0.00001) was found, ie, the lower the MIP, the higher the Pmosn/MIP ratio, suggesting an increasing difficulty in performing MIP as MIP values decreased. The majority of patients were between the prediction limits of the regression calculated for control subjects. At variance, patients with Duchenne dystrophy and low MIP were under the prediction limits of the regression calculated for control subjects, indicating a lower-than-expected Pmosn. Conclusions: In patients with NNMD, irrespective of the etiology, we found the following: (1) Pmosn does not overcome the limitations of MIP measurement; (2) the two maneuvers are not interchangeable, but rather complement one another in the assessment of inspiratory muscle strength; (3) Pmosn may underestimate muscle strength as assessed by MIP in patients with NNMD with inspiratory muscle weakness; and (4) in patients with low MIP, the lower-than-expected Pmosn/MIP ratio confirms inspiratory muscle weakness.
R
espiratory pump failure is one of the main causes of death in patients with neurologic and neuromuscular diseases (NNMD). 1 Thus, the assessment of respiratory muscle force is mandatory in these patients in order to identify those subjects at risk of impending respiratory failure. The measure of static maximal mouth pressure during maximal inspiratory efforts against an occluded airway 2,3 is the technique most commonly used to assess inspiratory muscle strength, even though it has some important limitations. Several factors, such as differences in technique, subject motivation and cooperation, and intersubject variability in the pattern of respiratory muscle recruitment, 4 ,5 affect maximal inspiratory pressure (MIP) measurement, so that the normal range for this measure is wide and varies between laboratories. 2,6 -10 In addition, in patients with NNMD, MIP can underestimate the inspiratory muscle strength, due to facial muscle weakness and the consequent difficulty in gripping the mouthpiece. Alternatively, Koulouris and coworkers 11 have shown, in a small group of normal subjects and patients with respiratory muscle weakness, that measurements of nasopharyngeal and mouth pressure predict reliably esophageal pressure during the sniff maneuver. The technique proposed by Koulouris et al 11 might be more useful than MIP for evaluating inspiratory muscle strength in NNMD patients, since it is simple, noninvasive, with a smaller range of normal values, and does not require gripping the mouthpiece. The reliability of this technique has been assessed in normal subjects [11] [12] [13] and in patients with muscle weakness of different origin, 11, 14 but to our knowledge, no specific studies have been carried out in patients with NNMD. In the present article, we compared mouth pressure during sniff maneuver (Pmosn) with MIP in the evaluation of inspiratory muscle strength in a group of patients with heterogeneous NNMD.
Materials and Methods

Subjects
We studied 30 white patients (21 LGD ϭ limb-girdle dystrophy; MS ϭ multiple sclerosis; DD ϭ Duchenne dystrophy; QP ϭ quadriplegia; SMD ϭ Steinert myotonic dystrophy; BD ϭ Becker dystrophy; F ϭ female; M ϭ male; FSHD ϭ facioscapulohumeral dystrophy; %pred ϭ percent predicted.
In patients with quadriplegia, a high-level spinal lesion (C3 to C6) was found; spasticity was also present in quadriplegics and in multiple sclerosis patients as well. No patient presented clinically evident ataxia. This study was approved by the local ethics committee, and informed consent was obtained.
Measurements
All measurements were made while the subjects were seated in a comfortable high-backed armchair. Spirometry was performed by the standard technique using a water-sealed spirometer (Pulmonet III; Sensormedics; Bilthoven, The Netherlands). The normal values for lung volumes are those proposed by the European Community for Coal and Steel. 15 The procedure and the apparatus (Fig 1) to measure MIP were a modification of those proposed by Black and Hyatt. 2, 3 We used a standard rubber-flanged mouthpiece connected to a metal tube 3 cm in diameter and 10 cm long with a small air leak to prevent the closing of the glottis, and to a tap allowing the airway to be closed. The apparatus was held by the investigator in the patient's mouth behind the lips, gripped by the teeth. Maximal static inspiratory efforts were performed at functional residual capacity (FRC), and the highest pressure sustained for 1 s was measured with a differential pressure transducer (Validyne; Northridge, CA). The determinations were repeated until three measurements with Ͻ 5% variability were recorded, and the higher value was used for the data analysis.
Mouth pressure was measured during maximal sniff maneuvers (Pmosn) with a 5-cm latex balloon-catheter system obtained by modifying a standard 10-cm latex balloon-catheter system (Fig 1) . The optimal volume of air for the small balloon was determined as follows. An approximate 250-mL volume rigid chamber was connected to a pressure transducer by means of a rigid catheter; the modified balloon-catheter system was placed inside the chamber and connected to another pressure transducer. Eight progressive volumes of air in the balloon (from 0.3 to 1 mL with steps of 0.1 mL) were tested; at each step, 30 to 40 negative pressure spikes of variable intensity were applied to the chamber, and the corresponding pressures recorded by the two transducers were collected onto an analog/digital personal computer card and then onto a hard disk for successive analysis. The agreement between the two pressure measures was analyzed according Bland and Altman. 16 The best agreement between the two systems was obtained with 0.5 and 0.6 mL of air in the modified balloon.
The balloon-catheter system was connected to a Validyne differential pressure transducer. The balloon was held in the oral cavity with the lips closed. 11 The subjects were instructed not to bite the catheter, or compress or apply suction to the balloon with the tongue during sniffs. 11 Subjects, without wearing noseclips, were asked to perform maximal short sniffs at FRC; the maneuver was repeated with a pause of quiet breathing lasting at least 10 s until three measurements with Ͻ 5% variability were recorded. The highest value of Pmosn obtained was used for the data analysis. Only Pmosn meeting the following criteria 11 were considered suitable for the analysis: (1) total sniff time of Ͻ 500 ms, (2) smooth waveform, and (3) peak pressure sustained for Ͻ 50 ms.
Magnetometers were used to assess changes in the anteroposterior diameter of the rib cage 17 to ensure that subjects performed MIP and Pmosn at FRC. All signals were recorded continuously on a multichannel paper recorder (Gould TA4000; Gould Instrument Systems; Valley View, OH). During both MIP and Pmosn maneuvers, the patients and the normal subjects were repeatedly encouraged to try as hard as possible, and they had a visual feedback of generated pressure.
Protocol
All subjects were tested in the afternoon. Lung function tests were performed first; after a 30-min rest period, MIP and Pmosn maneuvers were performed in random order. Between the two series of maneuvers, the subjects rested for 60 min.
Statistical Methods
Data were averaged and expressed as mean Ϯ SD. The lower limit of normal range for both MIP and Pmosn was obtained subtracting 2 SD from the mean value of normal subjects. Data comparisons were performed by Student's paired and unpaired t O, respectively; not significant). The average Pmosn/MIP ratio in patients was 0.86 Ϯ 0.35, ranging from 0.47 to 1.94 in male patients and from 0.39 to 1.28 in female patients. A significant positive relationship was found between MIP and Pmosn both in control subjects (r ϭ 0.49, p Ͻ 0.001) and in patients (r ϭ 0.785, p Ͻ 0.00001).
In control subject but not in patients, a significant inverse relationship between Pmosn/MIP ratio and MIP (r ϭ Ϫ 0.66, p Ͻ 0.00001) was found (Fig 2) . As it clearly is shown in Figure 2 , in subjects with MIP values Ͼ 110 cm H 2 O, Pmosn was lower than MIP (Pmosn/MIP ratio Ͻ 1), while in subjects with MIP values Ͻ 110, Pmosn was higher than MIP (Pmosn/MIP ratio Ͼ 1). The vast majority of patients were between the prediction limits calculated for control subjects, while all but one Duchenne dystrophy patients were below the prediction limits.
Discussion
The main findings of the present study can be summarized as follows: (1) in control subjects, the variation coefficients for MIP and Pmosn were similar, and the Pmosn/MIP ratio was inversely related to MIP; and (2) the majority of patients were between the prediction limits calculated for control subjects, and most patients with Duchenne dystrophy were below them.
Before commenting on these findings, it is important to raise some methodologic considerations. First, differences in training and familiarity of subjects with the two tests might have affected the present results. However, all of the normal subjects and patients included in the present study were naive and had not previously been involved in respiratory experiments and measurements of respiratory muscle strength. Furthermore, patients and normal subjects were similarly encouraged in performing the two tests and had a visual feedback of mouth pressure. Second, the measurement of MIP is influenced by the technique used so that high or low values may be measured according to the method employed. Higher MIP values are recorded when, as proposed by Black and Hyatt, 2 a circular rubber tube mouthpiece is used instead of a standard rubber flanged mouthpiece, 18 as we did in our subjects. To avoid the high MIP values linked to activation of mouth muscles, we used a small leak in the circuit, which lets the mouth muscle pressure dissipate. 9 Thus, technical factors do not appear to have influenced our measurement of MIP. Respiratory muscle weakness results in a decrease in maximal inspiratory and maximal expiratory static pressures. 3, 19 Thus, MIP can be used to follow the progression of the disease and the response to therapy, such measurement being especially helpful in monitoring a patient with impending respiratory failure. 20 However, MIP presents several limitations, such as the wide normal range and the variability between laboratories. At variance, measures of maximal esophageal and/or transdiaphragmatic pressures during sniff maneuvers have been found to be more reproducible and to have a smaller range of normal values when compared to MIP, 21,22 but they are not suitable for large clinical application, since they are invasive, complex, and not easy to readminister. At variance, Pmosn might be a useful alternative to MIP as a tool for monitoring inspiratory muscle strength in the clinical setting. 11 In the present study, however, the intersubject variability was similar for MIP as for Pmosn in normal subjects, suggesting that Pmosn was not a better test than MIP for detecting inspiratory muscle weakness. These results are consistent with those of Hé ritier et al, 14 who showed that the reproducibility of Pmosn was less than that of MIP in patients with acute respiratory failure.
A further limitation of MIP as a means of evaluating inspiratory muscle strength in patients with NNMD is that the weakness of the facial muscles can prevent some subjects from gripping the mouthpiece securely, leading to overdiagnosis of inspiratory muscle weakness as assessed in terms of MIP. 10, 21 The measurement of the pressure generated during a maximal sniff, that does not require noseclips and mouthpiece, should theoretically overcome this limitation. 21 Unlikely, the present findings show that MIP was significantly higher than Pmosn in patients; however, in the two patients with clear facial muscle weakness, the Pmosn/MIP ratio was Ͼ 1, suggesting that in this particular subset of patients Pmosn may overcome the limits of MIP.
The observation that both in control subjects and patients there was a wide range of Pmosn/MIP ratios confirms that these two maneuvers are not interchangeable but rather complement one another in the assessment of inspiratory muscle strength. 12 In Figure 2 . Relationship of Pmosn/MIP ratio to MIP in patients and control subjects. Only in control subjects was the relationship significant (r ϭ Ϫ0.66, p Ͻ 0.00001). A regression line with prediction limits is shown.
control subjects, the Pmosn/MIP ratio was related inversely to MIP, ie, the lower the MIP, the greater the Pmosn. This suggests that subjects who were able to perform both maneuvers correctly exhibited similar values of MIP and Pmosn, their ratio approximating the unit. Conversely, in subjects who were not able to perform either maneuver correctly, the ratio was either greater than or less than the unit. In patients this relationship was not significant; some of them (35.7%), mainly those with Duchenne dystrophy who exhibited a MIP value under the lower limit for control subjects (80 cm H 2 O), were under the prediction limits of the regression calculated for control subjects (Fig 2) . Thus, unlike control subjects, in whom the lower the MIP the higher the Pmosn/MIP ratio, patients with low MIP had a Pmosn lower than MIP, suggesting that Pmosn underestimates MIP in patients with weak inspiratory muscles. Our findings are consistent with the results of Héritier et al, 14 who showed that Pmosn systematically underestimates inspiratory muscle strength in the weakest patients with acute respiratory failure of different origin. Nevertheless, our results were obtained in patients in clinically stable condition, while the results of Héritier et al 14 were obtained in situations where a lack of inspiratory muscle coordination was likely. A factor that might contribute to the systematic underestimation of MIP by Pmosn in NNMD patients with muscle weakness is a low transnasal pressure gradient during sniffs leading to an incomplete collapse of the nasal valve. 13, 14 The results of the present study are not in agreement with those of Kolouris et al, 11 who reported that Pmosn reliably predicts maximal esophageal pressure during the sniff maneuver. The difference between our findings and the findings of Kolouris et al 11 cannot be explained on the basis of the present data. We can only speculate that in some subjects the presence of the balloon in the oral cavity may elicit an unpleasant sensation affecting inspiratory muscle recruitment and coordination during the maneuver.
Finally, we failed to find a specific pattern of Pmosn/MIP ratio in patients with NNMD, apart from Duchenne dystrophy patients.
In conclusion, the present data show the following: (1) Pmosn does not help overcome the limitations of MIP measurement; (2) the two maneuvers are not interchangeable but rather complementary in the assessment of inspiratory muscle strength; (3) Pmosn may underestimate muscle strength as assessed by MIP in NNMD patients with inspiratory muscle weakness, while in patients with clear facial muscle weakness, Pmosn may work better than MIP; and (4) in patients with low MIP, the lower than expected Pmosn/MIP ratio confirms inspiratory muscle weakness.
